BioStock has published an interview with Cereno Scientific’s CMO and Head of R&D, Dr. Rahul Agrawal
Cereno Scientific (Nasdaq First North: CRNO B), a company developing innovative treatments for common and rare cardiovascular disease, today announced that an article by BioStock has been published containing an interview with Cereno’s new Chief Medical Officer (CMO) and Head of R&D, Dr. Rahul Agrawal, on his previous experience and new role in the company.Read the article here . For further information, please contact: Henrik Westdahl, Director IR & Communications Email: henrik.